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Nanoscience and nanotechnology offer new
opportunities for making superior materials
for use in industrial and health applications
(Anselmann 2001; Doumanidis 2002;
Emerich and Thanos 2003; Falkenhagen
1995; Lowe 2002; McAllister et al. 2002). As
these materials develop and become more
widespread, there are many questions as to
the consequences that nanomaterials may
have on the environment. In fact it is clear
from some of the recent literature that the full
impact, or even partial impact, of manufac-
tured nanomaterials on human health and the
environment has yet to be fully explored
(Borm 2002; Colvin 2003; Dagani 2003;
Gogotsi 2003; Guzman et al. 2006; Hardman
2006; Kleiner and Hogan 2003; Masciangioli
and Zhang 2003; Nel et al. 2006; Oberdörster
et al. 2005a, 2005b). 
Nanoparticles, the primary building
blocks of many nanomaterials, may become
suspended in air during production, distribu-
tion, and use. Therefore, manufactured
nanoparticles can become a component of
indoor and outdoor environments and thus
the air we breath. Because these particles are
in the respirable size range, it is important to
investigate the potential health effects of these
particles that are suspended in air as aerosol
(Bang and Murr 2002; Oberdörster et al.
2005b; Wilson and Spengler 1996). 
Commercial engineered nanoparticles join
a class of particles known as ultraﬁne particles
whose size is < 100 nm. Ultraﬁne particles are
known to have greater adverse health effects
than larger particles (Daigle et al. 2003;
Oberdörster et al. 2005a; Wilson and Spengler
1996) because of their extremely high surface
areas and the ability to deposit in the alveoli
(Daigle et al. 2003; Oberdörster et al. 2005b;
Wilson and Spengler 1996). Because manufac-
tured nanoparticles are a specific subset of
ultraﬁne particles, it is reasonable to surmise
that they may have similar deleterious health
effects if inhaled.
In this study the potential effects of manu-
factured nanoparticles on human health have
been investigated. Here we report on an acute
and subacute exposure study of titanium diox-
ide (TiO2) nanoparticles with a primary parti-
cle size between 2 and 5 nm. Although there
have been earlier inhalation studies on TiO2
ultrafine particles (Bermudez et al. 2004),
these have been conducted with particle sizes
≥ 20 nm. There is some evidence that TiO2
nanoparticles with a primary particle size
< 10 nm may have chemical properties that are
distinct. Studies have shown that the surface
adsorption and reactivity of TiO2 nanoparticles
approximately 6 nm in diameter were
enhanced relative to nanoparticles near 16 nm
in diameter. Specifically, it has been shown
that the Langmuir adsorption constant, Kads,
the equilibrium constant measured for the
adsorption of a series of carboxylic acids from
solution on to the surface of the TiO2
nanoparticles was found to be much greater for
the smaller TiO2 nanoparticles relative to the
larger nanoparticles (Zhang et al. 1999).
Differences in adsorption constants were for
some carboxylic acids > 1,000 times for 6-nm
nanoparticles, that is, Kads (6 nm)/Kads (16 nm)
> 1,000. These results suggest that TiO2
nanoparticles < 10 nm in diameter could
exhibit different properties than the nano-
particles > 10 nm that have been previously
investigated in instillation and inhalation toxi-
cologic studies.
Besides investigating the smallest commer-
cially available TiO2 nanoparticles to date in
an inhalation toxicology study, another
unique aspect of the studies reported herein is
that a number of analytical methods and tech-
niques have been used to characterize the bulk
and surface properties of the TiO2 nanoparti-
cles. These analytical techniques include pow-
der X-ray diffraction (XRD), transmission
electron microscopy (TEM), Braunner,
Emmett, and Teller (BET) surface area meas-
urements, attenuated total reﬂection Fourier
transform infrared (ATR-FTIR) spectroscopy
and X-ray photoelectron spectroscopy (XPS).
These well-characterized particles were used
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BACKGROUND: Nanotechnology offers great promise in many industrial applications. However,
little is known about the health effects of manufactured nanoparticles, the building blocks of
nanomaterials.
OBJECTIVES: Titanium dioxide (TiO2) nanoparticles with a primary size of 2–5 nm have not been
studied previously in inhalation exposure models and represent some of the smallest manufactured
nanoparticles. The purpose of this study was to assess the toxicity of these nanoparticles using a
murine model of lung inﬂammation and injury. 
MATERIALS AND METHODS: The properties of TiO2 nanoparticles as well as the characteristics of
aerosols of these particles were evaluated. Mice were exposed to TiO2 nanoparticles in a whole-
body exposure chamber acutely (4 hr) or subacutely (4 hr/day for 10 days). Toxicity in exposed
mice was assessed by enumeration of total and differential cells, determination of total protein, lac-
tate dehydrogenase (LDH) activity and inﬂammatory cytokines in bronchoalveolar lavage (BAL)
ﬂuid. Lungs were also evaluated for histopathologic changes
RESULTS: Mice exposed acutely to 0.77 or 7.22 mg/m3 nanoparticles demonstrated minimal lung
toxicity or inﬂammation. Mice exposed subacutely (8.88 mg/m3) and necropsied immediately and
at week 1 or 2 postexposure had higher counts of total cells and alveolar macrophages in the BAL
ﬂuid compared with sentinels. However, mice recovered by week 3 postexposure. Other indicators
were negative.
CONCLUSIONS: Mice subacutely exposed to 2–5 nm TiO2 nanoparticles showed a signiﬁcant but
moderate inﬂammatory response among animals at week 0, 1, or 2 after exposure that resolved by
week 3 postexposure.
KEY WORDS: aerosol, inhalation toxicology study, murine models, nanoparticles, nanotoxicity, par-
ticle aggregation, surface area, titanium dioxide. Environ Health Perspect 115:397–402 (2007).
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formed in the inhalation exposure chamber
was characterized further by gravimetric meas-
urements, scanning mobility particle sizing
(SMPS), and TEM so that the total mass con-
centration of the nanoparticles as well as the
aggregation of the particles in the aerosol
could be assessed. The importance of charac-
terizing nanoparticles in health-related studies,
as we have done here, has been discussed
recently in detail by the International Life
Sciences Institute Research Foundation/Risk
Science Institute Nanomaterial Toxicity
Screening Work Group (Oberdörster et al.
2005a).
Materials and Methods
Source of nanoparticles. We purchased the
smallest commercially available TiO2
nanoparticles from Nanostructured and
Amorphous Materials (Los Alamos, NM).
The manufacturer’s specifications indicated
that the powdered material is composed of
TiO2 nanoparticles with an average primary
particle size of 5 nm and a surface area of
2 1 0±1 0m 2/g. 
Characterization of nanoparticles. Bulk
properties were characterized by powder XRD
(Bruker D-5000 q - q diffractometer with
Kevex energy-sensitive detector; Bruker AXS,
Inc., Madison, WI) and TEM (JEOL JEM-
1230, JEOL, Ltd., Peabody, MA). Powder
XRD is used to measure crystalline phase, as
this technique can readily differentiate crys-
talline phases by the intensity of the Bragg
X-ray reflections as a function of scattering
angle (Atkins and de Paula 2002). Thus, for
the TiO2 nanoparticles investigated here, the
X-ray diffraction pattern measured can be
compared with known diffraction patterns for
the crystalline phases of TiO2: anatase, rutile,
and brookite. TEM was used to measure
primary particle size and the aggregation of
the aerosol. 
We used several techniques to measure
surface properties, as there is some evidence
that surface properties may play an important
role in particle toxicity (Oberdörster et al.
2005b; Tran et al. 2000). We determined sur-
face areas of the powders using an automated
multipoint BET surface area apparatus (Nova
1200; Quantachrome Instruments, Boynton
Beach, FL). Surface chemical composition and
functionality were determined by XPS
(custom-designed Ultra-Axis XPS system;
Kratos, Manchester, UK) and ATR-FTIR
spectroscopy. The ATR-FTIR measurements
were made using a zinc selenide horizontal cell
from Pike Technologies (Madison, WI). We
placed the horizontal cell inside a Nicolet
Thermo Electron FTIR spectrometer (Nexus
670; Thermo Electron Corp., Madison, WI)
for these measurements.
Exposure system—apparatus and protocol.
In these studies, we used a 65-L aluminum,
dynamic whole body exposure chamber
(O’Shaughnessy et al. 2003). This chamber
was designed to operate within a standard
fume hood and hold up to 24 mice in open
mesh cages suspended above bedding material
to maximize the free ﬂow of particles around
the mice and minimize crowding. The pri-
mary air flow rate of 25 L/min was drawn
through the chamber with a rotary vane vac-
uum pump and measured with a calibrated
rotameter (Figure 1). Inflowing air passed
through a tube ﬁlled with desiccant to remove
water vapor and then through a high-effi-
ciency particulate air (HEPA) ﬁlter. We added
a small blower before the desiccant tube to
maintain a balanced static pressure in the
chamber that was slightly positive in order to
prevent room air particles from entering
the chamber. 
Aerosol generation and characterization.
To produce a nanoparticle aerosol, we sus-
pended a measured amount of the bulk powder
in water conditioned by reverse osmosis and
ultraﬁltration. Previous trials indicated that a
powder concentration of 2.5 mg/mL produced
an aerosol concentration of 7–10 mg/m3.
Immediately after adding the powder to the
water, the solution was sonicated by a high fre-
quency probe (model 550; Fisher Scientific,
Pittsburgh, PA) for 10 min. We then added the
solution to the reservoir of a six-jet Collison
nebulizer (BGI Inc., Waltham, MA). The neb-
ulizer was operated at 20 psi from a HEPA-ﬁl-
tered air source. A T-connection joined the
nebulizer output tube to the primary air stream.
Filtered and dried air of the primary stream
then carried the nebulized droplets through a
heated brass pipe to completely evaporate the
droplets. The dried powder aerosol then passed
through a static discharge device (bipolar ion
source; Simco Corp., Hatﬁeld Township, PA)
before entering the chamber. 
We measured the size distribution of the
aerosol in the chamber with a scanning
mobility particle sizer (SMPS) consisting of a
condensation particle counter (model 3010;
TSI Inc., St. Paul, MN) and an electrostatic
classifier with a “long” differential mobility
analyzer (model 3071; TSI Inc., St. Paul,
MN) that measured particles in the range of
7.5–311 nm. We calibrated the SMPS before
the inhalation study with 59- and 83-nm
polystyrene latex spheres. We placed copper
TEM grids (400 mesh; Ted Pella, Inc.,
Redding, CA) in the chamber during several
trial days to determine the aggregation by
TEM. We measured the time-integrated mass
concentration of the aerosol in the chamber
by gravimetric analysis of a 47-mm glass-ﬁber
ﬁlter placed in a stainless-steel ﬁlter holder in
line with the exhaust air flow. We measured
pre- and postweights with a calibrated
microbalance (model MT5; Mettler-Toledo
Inc., Columbus, OH) placed in a dedicated
climate controlled room. 
Animals. In this study we used 6-week-
old male C57Bl/6 mice (The Jackson
Laboratory, Bar Harbor, ME), which were
held in quarantine for 12 days before the start
of exposure, in an onsite, Association for
Assessment and Accreditation of Laboratory
Animal Care–accredited vivarium in poly-
propylene, fiber-covered cages in HEPA-fil-
tered Thoren caging units (Thoren Caging
Systems, Inc., Hazleton, PA). Mice were sup-
plied with food (sterile Teklad 5% stock diet;
Harlan, Madison, WI) and water ad libitum
and maintained on a 12-hr light-dark cycle.
The average animal weights at the time of
necropsy were 22 and 25 g (in acute and sub-
acute studies, respectively). Animal protocols
were approved by the Institutional Animal
Care and Use Committee and complied with
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Figure 1. Small whole-body exposure chamber used in these studies for nanoparticle inhalation exposure
studies. An aerosol-laden flow stream is generated with a nebulizer. After passing through a dryer the
flow stream is sent into the exposure chamber. Nanoparticle concentrations and size distributions are
measured using gravimetrical analysis and the SMPS, respectively. A TEM stub placed inside of the expo-
sure chamber is also used for characterization. See ”Materials and Methods” for further details.
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airthe NIH Guide for the Care and Use of
Laboratory Animals (Institute of Laboratory
Animal Resources 1996). 
Inhalation exposure protocol. We exposed
mice in groups of six to TiO2 nanoparticles
for 4 hr on one occasion (acute studies) or for
4 hr/day, for 10 days (subacute studies). Mice
exposed to nebulized water and sentinel mice
served as controls. In the subacute study, we
necropsied one group immediately after the
last day of exposure (week 0), the remaining
animals were euthanized in groups at weeks 1,
2, and 3 postexposure.
Evaluation of bronchoalveolar lavage
(BAL) ﬂuid. We euthanized animals with an
overdose of halothane. BAL fluid was col-
lected, processed, and used for enumeration
of total and differential cell counts as previ-
ously described (Thorne et al. 2006). The
lavage supernatants were split into aliquots
and frozen at –80°C for analysis of total pro-
tein, lactate dehydrogenase (LDH) activity
and cytokine levels. We determined total pro-
tein using the commercially available
Bradford protein assay (Bio-Rad Laboratories,
Inc., Hercules, CA) with bovine serum albu-
min as the standard. LDH activity released
from the cytosol of damaged cells into the
supernatant was measured spectrophotometri-
cally with a commercially available detection
kit (Roche Diagnostics, Penzberg, Germany).
We measured the concentrations of pro-
inflammatory cytokines interferon (IFN)-γ,
interleukin (IL)-6, and IL-1β in the super-
natants of BAL ﬂuids using multiplexed ﬂuo-
rescent bead-based immunoassays (Bio-Rad
Laboratories, Inc.).
Lung histopathology. After collection of
BAL fluid, we perfused lungs with 10%
formaldehyde–phosphate-buffered saline
(PBS) solution via the canulated trachea and
stored the perfusate overnight at room tem-
perature. The tissue was subsequently parafﬁn-
embedded, sectioned at 5 µm, and stained
with hematoxylin and eosin (H&E) and
Masson’s trichrome as previously described
(Thorne et al. 2006). Using routine light
microscopy, a pathologist quantitatively
assessed the tissue sections for histopathologic
abnormalities. The histologic variables assessed
included abnormalities of the parenchymal
architecture (bronchioles, alveoli, pleura, vas-
culature); abnormal inﬂammatory inﬁltrates;
presence or absence of acute lung injury; and
presence or absence of ﬁbrosis.
Statistical analyses. We performed statisti-
cal analyses in SAS (version 9.1; SAS, Inc.,
Cary, NC). Values are expressed as arithmetic
mean and standard error. Experimental groups
were compared with control groups using the
general linear model (GLM) and pairwise t-tests
for equal or unequal variances. In all analyses, a
p-value < 0.1 was considered suggestive of an
effect and < 0.05 was considered signiﬁcant. 
Results 
Particle characterization. Bulk properties
such as crystallinity and particle size were
characterized by powder X-ray diffraction and
TEM. The X-ray diffraction pattern showed
broadened lines at the expected diffraction
angles for anatase with no rutile present.
Anatase is the more stable form of TiO2 for
particles < 20 nm in diameter (Naicker et al.
2005). These lines are broadened because of
the small nanoparticle size. A TEM image of
TiO2 nanoparticles after suspending the parti-
cles in methanol and sonicating for a period
of time is shown in Figure 2A. The TEM
image shows that the primary nanoparticle
size is within a range of 2–5 nm in diameter.
Analysis of 100 nanoparticles yields an aver-
age particle size of 3.5 nm with a SD of
± 1.0 nm, which is smaller than that speciﬁed
by the manufacturer.
We characterized surface properties of the
TiO2 nanoparticles. We measured the BET
surface area to be 219 ± 3 m2/g, within the
range specified by the manufacturer (210 ±
10 m2/g). XPS surface analysis under ultrahigh
vacuum shows the presence of titanium, oxy-
gen, and small amount of adventitious carbon
in a survey spectrum (Moulder et al. 1992). A
higher resolution scan in the O(1s) region
(Figure 3A) showed a peak associated with
surface and near-surface oxygen atoms at a
binding energy of 530.1 eV. A second peak at
higher binding energy, 531.7 eV, was also evi-
dent and is associated with hydroxyl, O–H
groups, on the surface of the nanoparticle (Wu
et al. 2005). The ATR-FTIR spectrum col-
lected under ambient conditions is shown in
Figure 3B. Three absorption bands apparent
in the spectrum correspond to the bending
δ(H2O), and stretching, ν(H2O), vibrations
of water adsorbed on the surface of the
nanoparticles at 1,645 and 3,400 cm–1,
respectively, (Goodman et al. 2001). The
absorption band below 1,000 cm–1 was due to
oxide lattice vibrations of the TiO2 solid. The
surface analysis data are consistent with what
is known about oxide surfaces, namely they
are trunicated with surface O–H groups that
readily adsorb water on the surface under
ambient conditions. 
In situ aerosol characterization—SMPS
and TEM data. We used two methods for
aerosol characterization. The TEM image
shown in Figure 2B is of a nanoparticle aggre-
gate collected on the TEM stub placed in the
chamber during exposure. In situ analysis with
the SMPS revealed that the average TiO2 geo-
metric mean of the mobility diameter for all
Inhalation studies of 2–5 nm TiO2 nanoparticles
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Figure 2. TEM images of dispersed (A) and aggregated (B) TiO2 nanoparticles. Dispersed nanoparticles
show a primary nanoparticle size between 2 and 5 nm. For the generated aerosol, the TiO2 particles aggre-
gate to form larger particles as shown in B.
Dispersed nanoparticles Aggregated nanoparticles
Figure 3. (A) XPS spectrum in the O(1s) region show the presence of both O atoms and O–H groups on the
surface of the TiO2 nanoparticles. (B) The ATR-FTIR spectrum of TiO2 nanoparticles under ambient condi-
tions. The absorption bands in the spectrum are associated with the bending, δ(H2O), and stretching, ν(H2O),
modes of adsorbed water at 1,645 and 3,400 cm–1, respectively. The absorption band below 1,000 cm–1 is due
to TiO2 lattice vibrations.
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the subacute exposure was 128 nm with an
average geometric SD of 1.7. The aerosol size
distribution was consistent between days and
trial types. The fact that the geometric mean
diameter is much larger than the primary
particle size is again proof that the TiO2
nanoparticles formed aggregates. An addi-
tional peak in the SMPS distribution is seen
near 25 nm, which was also present for water
samples that contain no TiO2. This peak is
due to small amounts of impurities known to
be present even in the purest of water (Ho
et al. 1988; Krames et al. 1991). 
A summary of the physicochemical data
of the TiO2 nanoparticles and the aggregation
size of the nanoparticles in the inhalation
studies is given in Table 1. The exposure
results and analysis are described below. 
Exposure results and analysis. Acute
exposures. Mice were exposed acutely to low
(0.77 mg/m3) or high (7.22 mg/m3) concen-
trations of inhaled TiO2 nanoparticles and
necropsied immediately after the exposure
(Table 2). The number of total cells as well as
the number of macrophages was signiﬁcantly
(p < 0.05) increased in the BAL ﬂuid of ani-
mals exposed to high concentrations of TiO2
particles compared with negative controls (ani-
mals exposed to aerosolized water). However,
evaluation of number of neutrophils in BAL
fluid (Figure 4A), total protein, activity of
LDH (Table 3), and lung histopathology did
not reveal evidence of inﬂammation.
Subacute exposures. We exposed groups
of mice to inhaled TiO2 nanoparticles
4 hr/day, for 10 days. Average concentration
of nanoparticles in the whole-body exposure
chamber during subacute exposures was 8.88 ±
1.98 mg/m3 (Table 2). Assuming a minute
volume of 36 mL and deposition fraction 0.2,
the cumulative inhaled TiO2 dose was 154 µg
per mouse. All the animals exposed to TiO2
nanoparticles exhibited normal weight gain
and behaved similarly to sentinel mice during
the whole experiment. The number of alveolar
macrophages was elevated in the groups of ani-
mals necropsied at weeks 0, 1, and 2 postexpo-
sure (p < 0.075, p < 0.002, and p < 0.018,
respectively) but not in mice necropsied at
week 3 postexposure (p < 0.753) in compari-
son with the sentinel group (Figure 4B).
Neither neutrophils nor lymphocytes were sig-
niﬁcantly increased in the exposed groups of
animals compared with sentinels. Levels of
total protein and activity of LDH were not sig-
nificantly different from sentinels (Table 4).
Concentrations of cytokines measured in BAL
ﬂuid (IFN-γ, IL-6, and IL-1β) were very low,
with most values near or below the lower limit
of detection (0.14 pg/mL) and did not show
significant differences among groups
(Table 5). Histologic evaluation of lung tissue
showed no pathologic abnormalities. Dark
ﬁeld microscopy revealed large alveolar macro-
phages with phagocytized TiO2 particles as
shown in Figure 5. Figure 6 shows micro-
graphs of alveolar macrophages recovered
from BAL ﬂuid at weeks 0, 1, 2, and 3 post-
exposure. We have observed that macrophages
were less loaded with particles at week 3 post-
exposure compared with macrophages that
were recovered immediately postexposure. 
Discussion
Mice exposed to TiO2 nanoparticles with a
primary particle size of 2–5 nm showed little
response to acute inhalation exposure and a
modest but signiﬁcant inﬂammatory response
Grassian et al.
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Table 1. Summary of physicochemical characteriza-
tion data of TiO2 nanoparticles and TiO2 nanoparticle
aerosols.
Property Characterization
Crystalline or amorphous material Crystalline
Phase Anatase
Primary particle distribution 3.5 ± 1.0 nm
BET surface area 219 ± 3 m2/g
Surface functionalization O, O–H, H2O
Aerosol size distribution, GM (GSD)  123 nm (1.6)a
120 nm (1.6)b
128 nm (1.7)c
Abbreviations: GM, geometric mean; GSD, geometric stan-
dard deviation.
aAcute exposure, low concentration. bAcute exposure,
high concentration. cSubacute exposure.
Table 2. Concentration of TiO2 nanoparticles in
whole-body chamber during exposure.
Study Exposure group na
Acute Controls 6
0.77 mg/m3 6
7.22 mg/m3 6
Subacute Controls 6
8.88 ± 1.98 mg/m3b 24
aNumber of animals. bExposure concentrations each day:
7.78, 7.91, 7.74, 7.78, 11.16, 9.09, 7.42, 7.62, 8.78, 13.55 mg/m3. 
Figure 4. Number of macrophages, neutrophils and lymphocytes in BAL ﬂuid among acutely (A) and sub-
acutely (B) exposed animals. Values are expressed as mean ± SE. 
*Signiﬁcantly different from control group, p < 0.05 (t-test for equal and unequal variances).
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Table 3. Results for the concentration of total protein and activity of LDH in BAL fluid (mean ± SE) from
mice acutely exposed to TiO2 nanoparticles.
TiO2 concentration
Sentinels Water 0.77  mg/m3 7.22 mg/m3
Total protein (µg/mL) 63 ± 2 79 ± 9 91 ± 7 83 ± 3
LDH activity (U/L) 32 ± 4 36 ± 6 51 ± 16 37 ± 6
Table 4. Results for the concentration of total protein and activity of LDH in BAL fluid (mean ± SE) from
mice subacutely exposed to TiO2 nanoparticles.
Weeks postexposure
Sentinels 0123
Total protein (µg/mL) 124 ± 7 112 ± 4 127 ± 16 135 ± 23 113 ± 6
LDH activity (U/L) 39 ± 9 31 ± 3 56 ± 5 57 ± 4 44 ± 10
Table 5. Concentration [pg/mL (mean ± SE)] of cytokines in BAL ﬂuid from mice subacutely exposed to TiO2
nanoparticles.
Weeks postexposure
Cytokinea Sentinels 0 1 2 3
INF-γ 0.15 ± 0.01 0.22 ± 0.06 0.23 ± 0.06 0.14 ± 0.00 0.15 ± 0.01
< L LOD/n 5/6 3/6 2/6 6/6 5/6
IL-6  0.50 ± 0.22 0.84 ± 0.49 0.22 ± 0.04 0.43 ± 0.09 0.27 ± 0.04
< L LOD/n 3/6 2/6 3/6 0/6 1/6
IL-1β 1.03 ± 0.27 0.63 ± 0.04 1.03 ± 0.47 0.51 ± 0.11 0.52 ± 0.18
< L LOD/n 0/5b 0/4b 0/6a 0/5b 2/6
aLower limit of detection (L LOD) is 0.14 pg/mL for all three cytokines. bFour mice with hemorrhagic BAL fluid were
excluded (one animal from the sentinel group, two from week 0 postexposure, and one from the group necropsied at
week 2 postexposure).to subacute exposure among animals necrop-
sied at week 0, 1, or 2 after the last exposure.
Mice exposed subacutely recovered at
week 3 postexposure. These manufactured
nanoparticles, with the highest commercially
available surface area and smallest particle size
for TiO2, did not show particularly toxic
effects in this subacute inhalation study. In
contrast, this murine model has demonstrated
robust inflammatory responses upon inhala-
tion of grain dust (Jagielo et al. 1996;
Mueller-Anneling et al. 2006) or endotoxin
(Thorne et al. 1999) with a high number of
total cells, neutrophils, or IL-6 or TNF-α lev-
els in BAL fluid. It should be noted, with
short-term inhalation exposures in rats to iron
nanomaterials, inflammatory responses were
also minimal (Zhou et al. 2003). 
These results are in conflict with the
notion that inﬂammatory response is expected
to be high with high surface area powders that
are composed of some of the smallest nano-
particles. A surface area dependence and corre-
lation have been observed in instillation studies
(Oberdörster 2005b). However, a recent instil-
lation study involving rats showed that the sur-
face area for TiO2 nanodots and nanorods was
not a significant factor in inflammatory
response (Warheit et al. 2006). The nanodots
had a > 6-fold increase in surface area compared
with the nanorods but showed similar responses
in total cell count, polymorphonuclear leuko-
cyte percent, and BAL composition. 
The resolution of inflammation after
nanoparticle exposure in our inhalation stud-
ies has also been observed in other short expo-
sure inhalation and instillation experiments of
TiO2 (Stoeger et al. 2006). Furthermore,
mice have shown quicker lung clearance than
rats with TiO2 nanoparticles (Bermudez et al.
2004; Hext et al. 2005), thus enhancing
recovery from TiO2 exposure. 
The moderate response to exposure
observed in our study may reflect a surface
area threshold effect. The surface area thresh-
old is the limit where inﬂammatory response
occurs independently of particle size and any-
thing below the threshold will cause little or
no inflammatory response. A threshold dose
has been discussed in previous studies of man-
ganese oxide particle toxicity (Lison et al.
1997). Recently, a total surface area threshold
was observed for a range of ultraﬁne carbona-
ceous particles (Stoeger et al. 2006). Stoeger
et al., showed in instillation exposure studies
of carbonaceous ultraﬁne particles there was a
surface area threshold for inflammatory
response for all of the different carbonaceous
materials investigated. Although previous
studies of TiO2 nanoparticles have not shown
similar thresholds in instillation experiments,
a total surface area threshold of 200–300 cm2
was found for > 2 µm particles during a
chronic inhalation study (Tran et al. 2000).
At present, it is difficult to compare instilla-
tion and inhalation experiments because little
is known about the aggregation state of the
nanoparticles in the instillation solution.
Conclusions
In this inhalation exposure study, we have
used TiO2 nanoparticles with a primary
particle size of 2–5 nm in diameter. Detailed
Inhalation studies of 2–5 nm TiO2 nanoparticles
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Figure 5. Dark field micrographs of lung tissue with H&E staining (A,B) and alveolar macrophages pre-
pared by cytospinning and H&E staining (C,D). (A,C) Sentinels and (B,D) animals subacutely exposed to
TiO2 nanoparticles with a primary particle size of 2–5 nm and necropsied immediately after the last expo-
sure . Arrows point to TiO2 nanoparticle-laden macrophages.
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C D
Figure 6. Dark field micrographs of alveolar macrophages prepared by cytospinning and H&E staining 
from mice exposed subacutely to TiO2 nanoparticles and necropsied at weeks 0 (A), 1 (B), 2 (C), and 3 (D)
postexposure. 
6 μm 6 μm
6 μm 6 μm
A B
C Dcharacterization of these nanoparticles showed
a smaller size than that speciﬁed by the manu-
facturer, indicating that batch-to-batch vari-
ability can occur in the manufacturing of
powders of oxide nanoparticles. Therefore, it
seems important to perform an independent
characterization of nanomaterials in toxicol-
ogy studies. These nanoparticles aggregate to
form an aerosol particle in the exposure
chamber with a geometric mean of the mobil-
ity diameter between 120 and 130 nm. Acute
exposures demonstrated no adverse effects
4 hr after the exposures commence. Analysis
of lung responses in mice after subacute expo-
sures to these aggregates showed a signiﬁcant
but modest inflammatory response among
animals necropsied at week 0, 1, or 2 after the
last exposure with recovery at week 3 post-
exposure. These studies indicate that inhaled
TiO2 nanoparticles with a primary particle size
< 10 nm induce relatively modest responses and
can serve as benchmark particles against which
other nanomaterials can be compared. 
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